H.R. 4178 · 116th Congress
REFUND Act of 2019
Key: what the circles and colors mean
Each circle is a bill. The ring fills as it moves through Congress:
Under the number: the Yea · Nay count of its final (or latest) recorded vote. On a member's page, the small badge is how that member voted: Y Yea / Aye, N Nay / No, P Present, – Not voting.
Gold and violet are only for Yea and Nay; they never mean a party. A member's party is the letter on their photo.
Never voted on. It didn't reach a floor vote before the 116th Congress ended, so it expired. A bill has to be introduced again to be considered in a new Congress.
D
EngelSponsorNo cosponsors.
Recovering Excessive Funds for Unused and Needless Drugs Act of 2019 or the REFUND Act of 2019
What it does: CRS summary · Introduced in House · Aug 9, 2019
Recovering Excessive Funds for Unused and Needless Drugs Act of 2019 or the REFUND Act of 2019
This bill requires drug manufacturers to issue rebates to the Centers for Medicare & Medicaid Services (CMS) in relation to discarded amounts (i.e., amounts remaining after administration) of single-dose vial drugs that are covered under Medicare. Manufacturers that fail to comply are subject to civil penalties.
The CMS must determine rebate amounts based on payment claims from providers. (Currently, providers may receive payment under Medicare for discarded amounts of single-dose vial drugs through the use of a specific claims modifier.)
Written by the nonpartisan Congressional Research Service. All summary versions on Congress.gov
About this bill and sources
Official title: REFUND Act of 2019
Also known as: Recovering Excessive Funds for Unused and Needless Drugs Act of 2019
Latest action (Aug 12, 2019): Referred to the Subcommittee on Health.
Policy area: Health · Origin: House · Introduced: Aug 9, 2019
Official page on Congress.gov · Bill text (GovInfo) · Status record (XML)
No recorded floor vote found.